• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Atrial Septal Defect and Pulmonary Arterial Hypertension

April 26, 2019 By Dr. Jeremy Feldman

Image Credit: CDC.gov

An Atrial Septal Defect (ASD) is a hole in the heart between the right and left top chambers (atria). This is not terribly uncommon with an estimated 1-2 per 1000 live births.  Most of these holes are small and do not cause long-term problems.  In some patients the hole is larger and can lead to extra blood flowing from the left side of the heart into the right side of the heart.  Over time this leads to the right ventricle having to do extra work and the pulmonary arteries carry extra blood flow.  

Changes in the Heart

The first changes that we see are that the right side of the heart begins to enlarge.  Then the pulmonary artery pressure begins to increase. At this time many patients will start to notice that they are tired or short of breath.  If you check your oxygen saturation during vigorous exercise you may find that your oxygen saturation drops.  At rest your oxygen saturation will still be normal.  Over time the pulmonary pressure will continue to rise and eventually severe Pulmonary Arterial Hypertension develops.  

Heart Murmur

Many patients who have an ASD will have a murmur in their heart.  This murmur or symptoms of shortness of breath eventually lead to an echocardiogram.  This ultrasound study generally will show the enlarged right side of the heart and increased pulmonary artery pressures.  Depending on the location and size of the hole, it may even be visible on the echocardiogram.  

Heart Catheterization and Other PAH Tests

A heart catheterization and exercise testing along with the usual battery of PAH tests (blood work, chest Xray, and breathing tests) are performed.  The heart catheterization is the most important test to determine if the hole in the heart should be closed.  Occasionally an MRI of the heart is helpful as well.  If there is evidence of a large hole and the pulmonary hypertension is only mild, then the hole is usually closed.  If the PAH is severe then we generally avoid closing the hole. 

Closure of an Atrial Septal Defect

Closure of an ASD can be done via a catheter-based procedure (through your groin using a long tube) or by an open-heart procedure.  When possible, the catheter-based procedure is always preferred.  Some holes are so large that only a surgery can fix the problem. 

Development of PAH

Some patients who have had their ASD closed may develop PAH several years later.  This could be due to lack of adequate testing to identify PAH prior to closure or PAH may simply develop a few years later.  When this happens we treat the PAH with our usual medications.  Prior to closing an ASD it is very important to carefully evaluate for PAH.  This is because a hole in the heart can actually be helpful once PAH develops.  

Most patients with an ASD will never develop PAH.  However, if you have been diagnosed with an ASD, you should be carefully evaluated for this problem.  Either a PAH expert or an expert in congenital heart disease can help quarterback this evaluation.  

Filed Under: Congenital Heart Disease

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Blood tests to monitor PH patients

What is BNP?

By Dr. Jeremy Feldman

BNP stands for B-type natriuretic peptide. This is a hormone that is released by the bottom two chambers of the heart

Why Abortion Matters to PAH Patients

By Dr. Jeremy Feldman

Across America a woman’s right to terminate an unwanted pregnancy is under threat. Without diving into politics or

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives